More recent research has demonstrated that G1 and G2 variant alleles may increase the risk of COVID-19-associated collapsing glomerulopathy [4, 8, 9], including in the case above where genetic testing revealed homozygous APOL1 mutation (G1 allele). Here, APOL1 is linked to COVID-19.